Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Romero

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Nature Communications|May 2, 2023
Synergistic binding sites in a metal-organic framework for the optical sensing of nitrogen dioxideIsabel Del Castillo-Velilla, Ahmad Sousaraei, Ignacio Romero-Muñiz, et al.
Pathology, Research and Practice|July 3, 2023
A shared origin from a common ancestor: A case report of two histologically different tumorsMaria Varea-Martínez, Eva García-Valero, Raquel López-Reig, et al.
Gynecologic Oncology|September 29, 2020
An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN studyIgnacio Romero, M Jesús Rubio, Manuel Medina, et al.
The American Journal of Surgical Pathology|September 10, 2019
The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group for Ovarian Cancer Research (GEICO)Susanna Leskela, Ignacio Romero, Eva Cristobal, et al.
Gynecologic Oncology|April 29, 2025
Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation: Final overall survival results from the OPINION trialAndrés Poveda, Stéphanie Lheureux, Nicoletta Colombo, et al.
Cell Metabolism|December 25, 2015
In Vivo Evidence for a Lactate Gradient from Astrocytes to NeuronsPhilipp Mächler, Matthias T Wyss, Maha Elsayed, et al.
International Journal of Molecular Sciences|July 14, 2023
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)David Pizarro, Ignacio Romero, Belén Pérez-Mies, et al.
BMC Cancer|July 3, 2023
Genomic landscapes of ovarian clear cell carcinoma from latin countries reveal aberrations linked to survival and progressionMariana de Paiva Batista, Martín Roffé, Ignacio Romero, et al.
The American Journal of Surgical Pathology|April 16, 2020
Mismatch Repair Deficiency in Ovarian Carcinoma: Frequency, Causes, and ConsequencesSusanna Leskela, Ignacio Romero, Eva Cristobal, et al.
The American Journal of Surgical Pathology|May 9, 2020
Molecular Heterogeneity of Endometrioid Ovarian Carcinoma: An Analysis of 166 Cases Using the Endometrial Cancer Subrogate Molecular ClassificationSusanna Leskela, Ignacio Romero, Juan M Rosa-Rosa, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Nature Communications|May 2, 2023
Synergistic binding sites in a metal-organic framework for the optical sensing of nitrogen dioxideIsabel Del Castillo-Velilla, Ahmad Sousaraei, Ignacio Romero-Muñiz, et al.
Pathology, Research and Practice|July 3, 2023
A shared origin from a common ancestor: A case report of two histologically different tumorsMaria Varea-Martínez, Eva García-Valero, Raquel López-Reig, et al.
Gynecologic Oncology|September 29, 2020
An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN studyIgnacio Romero, M Jesús Rubio, Manuel Medina, et al.
The American Journal of Surgical Pathology|September 10, 2019
The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group for Ovarian Cancer Research (GEICO)Susanna Leskela, Ignacio Romero, Eva Cristobal, et al.
Gynecologic Oncology|April 29, 2025
Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation: Final overall survival results from the OPINION trialAndrés Poveda, Stéphanie Lheureux, Nicoletta Colombo, et al.
Cell Metabolism|December 25, 2015
In Vivo Evidence for a Lactate Gradient from Astrocytes to NeuronsPhilipp Mächler, Matthias T Wyss, Maha Elsayed, et al.
International Journal of Molecular Sciences|July 14, 2023
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)David Pizarro, Ignacio Romero, Belén Pérez-Mies, et al.
BMC Cancer|July 3, 2023
Genomic landscapes of ovarian clear cell carcinoma from latin countries reveal aberrations linked to survival and progressionMariana de Paiva Batista, Martín Roffé, Ignacio Romero, et al.
The American Journal of Surgical Pathology|April 16, 2020
Mismatch Repair Deficiency in Ovarian Carcinoma: Frequency, Causes, and ConsequencesSusanna Leskela, Ignacio Romero, Eva Cristobal, et al.
The American Journal of Surgical Pathology|May 9, 2020
Molecular Heterogeneity of Endometrioid Ovarian Carcinoma: An Analysis of 166 Cases Using the Endometrial Cancer Subrogate Molecular ClassificationSusanna Leskela, Ignacio Romero, Juan M Rosa-Rosa, et al.
Pageof 12